Loading...
CureVac N.V.
5CV.DE•XETRA
Healthcare
Biotechnology
€3.91
€0.03(0.72%)
German Market opens in 62h 36m5CV.DE News Today: Stay Updated with the Latest CureVac N.V. News in Real Time
Find 5CV.DE news now at Meyka AI. Stay informed with the latest CureVac N.V. stocks updates, including price news, market analysis, and expert insights.
📅 16 days ago
MDG1.DE Medigene AG (XETRA) down 27% 18 Mar 2026: Oversold bounce trade to watch
MDG1.DE stock fell to €0.1335 on XETRA 18 Mar 2026. Deeply oversold; short-term bounce possible with model target €0.25
Read more
📅 3 months ago
BNTX News Today: BioNTech Completes CureVac Acquisition, December 19
Explore BioNTech’s latest acquisition of CureVac, enhancing its mRNA capabilities and growth potential. Investing insights included.
Read more
📅 4 months ago
BNTX News Today: BioNTech Completes CureVac Acquisition, December 19
BioNTech has finalized its acquisition of CureVac, enhancing its position in mRNA technology and impacting BNTX stock.
Read more
📅 7 months ago
CVAC News Today: CureVac’s mRNA Vaccine Advances Boost Stock
CureVac’s mRNA vaccine breakthroughs propel their stock, signaling a boost in investor confidence.
Read more
📅 7 months ago
CureVac News Today: Tübingen-Based Biotech Soars After Breakthrough mN
Discover CureVac’s groundbreaking mRNA vaccine research and its impact on Tübingen’s biotech stock market.
Read more